|
SCP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56920032523544E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.88600279627371E-11 |
| Normal-vs-Stage2 |
2.79560000038259E-07 |
| Normal-vs-Stage3 |
7.52930000014196E-07 |
| Normal-vs-Stage4 |
5.38290000018371E-07 |
| Stage1-vs-Stage2 |
9.687800E-01 |
| Stage1-vs-Stage3 |
5.415000E-01 |
| Stage1-vs-Stage4 |
4.954400E-01 |
| Stage2-vs-Stage3 |
6.766200E-01 |
| Stage2-vs-Stage4 |
4.754600E-01 |
| Stage3-vs-Stage4 |
8.163000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.49251788284755E-12 |
| Normal-vs-AfricanAmerican |
3.69260000354643E-09 |
| Normal-vs-Asian |
3.128200E-01 |
| Caucasian-vs-AfricanAmerican |
7.530600E-01 |
| Caucasian-vs-Asian |
5.167000E-01 |
| AfricanAmerican-vs-Asian |
5.577200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00609520714556E-11 |
| Normal-vs-Female |
8.37489966265537E-10 |
| Male-vs-Female |
7.428600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.94120003299747E-09 |
| Normal-vs-Extreme_Weight |
1.84297022087776E-12 |
| Normal-vs-Obese |
9.39459621207561E-11 |
| Normal-vs-Extreme_Obese |
7.971900E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.737400E-01 |
| Normal_Weight-vs-Obese |
8.907600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.895850E-01 |
| Extreme_Weight-vs-Obese |
9.973200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.416200E-01 |
| Obese-vs-Extreme_Obese |
1.463810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.0418999824301E-10 |
| Normal-vs-Age(41-60Yrs) |
4.17432755028813E-12 |
| Normal-vs-Age(61-80Yrs) |
3.10019787619353E-11 |
| Normal-vs-Age(81-100Yrs) |
8.153200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.351600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.341900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.633600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.248200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.197000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.731600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.3365753776261E-12 |
| Normal-VS-Type2 PRCC |
8.7362999945384E-08 |
| Normal-VS-KIRP CIMP |
2.01449967818235E-10 |
| Normal-VS-Unclassified PRCC |
2.42489994750628E-09 |
| Type1 PRCC-VS-Type2 PRCC |
3.731800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.344100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.421800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.84950000000318E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
2.864000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.062020E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.08039999169307E-09 |
| Normal-vs-N1 |
1.67519997873455E-10 |
| Normal-vs-N2 |
1.212980E-04 |
| N0-vs-N1 |
3.860600E-01 |
| N0-vs-N2 |
4.594000E-01 |
| N1-vs-N2 |
6.476200E-01 |
|
|
